Ventis Pharma Corporation is a biopharmaceutical company focused on developing and producing innovative pain management therapies. We create solutions to treat patients with a variety of post-operative pain and pain syndromes. We develop safe, effective, and suitable therapies for a wide variety of patient applications that serve both adults and children. We currently hold multiple patents, or have patents pending, in the US and 40 other countries for our long-acting, low-toxicity local anesthetic formulation, Enduracaine™. At Ventis Pharma, we conduct ongoing research and development activities for adjuvant agents to prolong pain relief interventions in a wide variety of patient care situations. Quite simply, our company focuses on developing innovative pain management solutions for medical professionals and while improving the healthcare experience for their patients.